Current Use of Antithymoglobulin As Induction Regimen in Kidney Transplantation: A Review

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2024 Mar 1

PMID 38428847

Authors

Byung Hwa Park

Ye Na Kim

Ho Sik Shin

Yeonsoon Jung

Hark Rim

Affiliations

Soon will be listed here.

Abstract

Currently, various immunosuppressive drugs are used in organ transplantation. In particular, antithymoglobulin is a widely used drug in kidney transplantation in Korea, accounting for 20% of all induction therapy. According to existing studies, antithymoglobulin induction therapy has several advantages and disadvantages compared with other immunotherapies depending on the kidney transplant situation (dead donor, living donor, low-risk recipient, and high-risk recipient) or antithymoglobulin dose. In this review, we summarize the research conducted so far on antithymoglobulin and hope that antithymoglobulin research on kidney transplantation will be actively conducted in the future.

References

Bachler K, Amico P, Honger G, Bielmann D, Hopfer H, Mihatsch M . Efficacy of induction therapy with ATG and intravenous immunoglobulins in patients with low-level donor-specific HLA-antibodies. Am J Transplant. 2010; 10(5):1254-62. DOI: 10.1111/j.1600-6143.2010.03093.x. View

Jeong E, Lee K, Kim S, Yoo H, Kim K, Park J . Comparison of clinical outcomes of deceased donor kidney transplantations, with a focus on three induction therapies. Korean J Transplant. 2022; 33(4):118-127. PMC: 9188948. DOI: 10.4285/jkstn.2019.33.4.118. View

De Greef K, Ysebaert D, Dauwe S, Persy V, Vercauteren S, Mey D . Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int. 2001; 60(4):1415-27. DOI: 10.1046/j.1523-1755.2001.00944.x. View

Woodle E, Peddi V, Tomlanovich S, Mulgaonkar S, Kuo P . A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation. Clin Transplant. 2009; 24(1):73-83. DOI: 10.1111/j.1399-0012.2009.01127.x. View

Laftavi M, Alnimri M, Weber-Shrikant E, Kohli R, Said M, Patel S . Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up. Transplant Proc. 2011; 43(2):458-61. DOI: 10.1016/j.transproceed.2011.01.035. View

Mathuram Thiyagarajan U, Ponnuswamy A, Bagul A . Thymoglobulin and its use in renal transplantation: a review. Am J Nephrol. 2013; 37(6):586-601. DOI: 10.1159/000351643. View

Lee J, Kim S, Park Y, Park J, Lee S, Yang J . Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry. Kidney Res Clin Pract. 2022; 41(5):623-634. PMC: 9576457. DOI: 10.23876/j.krcp.21.310. View

Veenstra D, Best J, Hornberger J, Sullivan S, Hricik D . Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis. 1999; 33(5):829-39. DOI: 10.1016/s0272-6386(99)70414-2. View

Mourad G, Garrigue V, Squifflet J, Besse T, Berthoux F, Alamartine E . Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation. 2001; 72(6):1050-5. DOI: 10.1097/00007890-200109270-00012. View

10.

Rabb H, Daniels F, ODonnell M, Haq M, Saba S, KEANE W . Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol. 2000; 279(3):F525-31. DOI: 10.1152/ajprenal.2000.279.3.F525. View

11.

Knight R, Devos J, Patel S, Land G, Moore L, Gaber L . Outcomes of living donor renal transplants with a negative cross-match and pretransplant donor-specific antibody. Transplant Proc. 2013; 45(4):1399-401. DOI: 10.1016/j.transproceed.2013.01.027. View

12.

Deeks E, Keating G . Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection. Drugs. 2009; 69(11):1483-512. DOI: 10.2165/00003495-200969110-00007. View

13.

Thomusch O, Wiesener M, Opgenoorth M, Pascher A, Woitas R, Witzke O . Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial. Lancet. 2016; 388(10063):3006-3016. DOI: 10.1016/S0140-6736(16)32187-0. View

14.

Ekberg J, Baid-Agrawal S, Jespersen B, Kallen R, Rafael E, Skov K . A Randomized Controlled Trial on Safety of Steroid Avoidance in Immunologically Low-Risk Kidney Transplant Recipients. Kidney Int Rep. 2022; 7(2):259-269. PMC: 8821032. DOI: 10.1016/j.ekir.2021.11.028. View

15.

Pratschke J, Dragun D, Hauser I, Horn S, Mueller T, Schemmer P . Immunological risk assessment: The key to individualized immunosuppression after kidney transplantation. Transplant Rev (Orlando). 2016; 30(2):77-84. DOI: 10.1016/j.trre.2016.02.002. View

16.

Grafals M, Smith B, Murakami N, Trabucco A, Hamill K, Marangos E . Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study. PLoS One. 2014; 9(8):e104408. PMC: 4128673. DOI: 10.1371/journal.pone.0104408. View

17.

Yokota N, Daniels F, Crosson J, Rabb H . Protective effect of T cell depletion in murine renal ischemia-reperfusion injury. Transplantation. 2002; 74(6):759-63. DOI: 10.1097/00007890-200209270-00005. View

18.

Liborio A, Mendoza T, Esmeraldo R, Oliveira M, Paes F, Silva Junior G . Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin. Int Immunopharmacol. 2011; 11(11):1832-6. DOI: 10.1016/j.intimp.2011.07.012. View

19.

Kim S, Rhu J, Yoo H, Kim K, Lee K, Park J . Outcome Comparison between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation. J Clin Med. 2020; 9(5). PMC: 7290680. DOI: 10.3390/jcm9051320. View

20.

Webster A, Pankhurst T, Rinaldi F, Chapman J, Craig J . Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: a systematic review of randomized trial data. Transplantation. 2006; 81(7):953-65. DOI: 10.1097/01.tp.0000215178.72344.9d. View